Sponsored Links

Former Pfizer CEO Kindler joins Lux Capital

Wed Aug 8, 2012 8:57pm EDT

Aug 8 (Reuters) - Jeff Kindler, the former chief executive of Pfizer Inc, has joined venture capital firm Lux Capital as a partner, Lux said in a statement, where he will help scout for healthcare investment opportunities and work with portfolio companies.

Kindler retired from Pfizer in December 2010 after eight years with the company and was replaced as CEO by Ian Read.

Apart from his new role at Lux Capital, Kindler also serves on the board of several other pharmaceutical and healthcare companies. He is also a member of U.S. President Barack Obama's management advisory board and a director at private equity firm Starboard Capital Partners.
Stocks
Markets
Mutual Fund Center
ETFs News
Private Capital
Financials
Healthcare
We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (1)
aero2 wrote:
Sell out of Lux Capital! Kindler with his Democratic leanings helped pursuade the R&D-oriented pharmaceutical manufacturers association (PhRMA) into supporting Obamacare, as well held sway over a precipitous decline in PFE’s stock price during his tenure as CEO.

Aug 08, 2012 9:37pm EDT  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
See All Comments »